Impact of rifampicin dose in bone and joint prosthetic device infections due to Staphylococcus spp: a retrospective single-center study in France

BACKGROUND: Prosthetic joint infections (PJI) are a major cause of morbidity and mortality burden worldwide. While surgical management is well defined, rifampicin (RIF) dose remains controversial. The aim of our study was to determine whether Rifampicin dose impact infection outcomes in PJI due to S...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:BMC Infect Dis
Glavni autori: Tonnelier, M., Bouras, A., Joseph, C., Samad, Y. El, Brunschweiler, B., Schmit, J.-L., Mabille, C., Lanoix, J-P
Format: Artigo
Jezik:Inglês
Izdano: BioMed Central 2021
Teme:
Research Article
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7881571/
https://ncbi.nlm.nih.gov/pubmed/33579208
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12879-021-05832-2
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items